Stomach ulcer (SU) ranks first among the digestive tract diseases. According to statistics, today it affects 10 to 15% of the world population. The leading role in the development of this pathology is played by Helicobacter pylori, which provokes the destruction of mucous membranes. SU treatment is selected based on diagnostics results. In the absence of complications, conservative therapies are indicated to patients.
The diagnosis is made on the basis of complaints, clinical examination and case history. Additionally, the patient is prescribed a set of tests:
- complete blood count,
- biochemical blood test,
- abdominal ultrasound,
- urease test to identify Helicobacter pylori.
Mucosal infection with H. pylori is a risk factor for gastric cancer. Therefore, when the urease test yields positive results, the diagnostic activities aimed at detection of neoplastic processes are performed:
- hemoccult test,
- gastroscopy with biopsy.
The disease treatment is reduced to elimination of its cause, suppression of symptoms and prevention of complications. All patients are given advice on nutrition correction. Upon detection of H. pylori, the antibiotic therapy is administered. To alleviate the condition, antispasmodics, antacids, astringents and other drugs are prescribed. The treatment efficacy is monitored by endoscopy. The further tactics of actions is developed for each case individually.